Literature DB >> 33851392

Brain Injury in Extracorporeal Membrane Oxygenation: A Multidisciplinary Approach.

Giovanni Chiarini1,2, Sung-Min Cho3, Glenn Whitman4, Frank Rasulo2, Roberto Lorusso1,5.   

Abstract

Extracorporeal membrane oxygenation (ECMO) represents an established technique to provide temporary cardiac and/or pulmonary support. ECMO, in veno-venous, veno-arterial or in extracorporeal carbon dioxide removal modality, is associated with a high rate of brain injuries. These complications have been reported in 7 to 15% of adults and 20% of neonates, and are associated with poor survival. Thromboembolic events, loss of cerebral autoregulation, alteration of the blood-brain barrier, and hemorrhage related to anticoagulation represent the main causes of severe brain injury during ECMO. The most frequent forms of acute neurological injuries in ECMO patients are intracranial hemorrhage (2-21%), ischemic stroke (2-10%), seizures (2-6%), and hypoxic-ischemic brain injury; brain death may also occur in this population. Other frequent complications are infarction (1-8%) and cerebral edema (2-10%), as well as neuropsychological and psychiatric sequelae, including posttraumatic stress disorder. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33851392     DOI: 10.1055/s-0041-1726284

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  3 in total

Review 1.  Mechanical Ventilation in Patients with Traumatic Brain Injury: Is it so Different?

Authors:  Shaurya Taran; Sung-Min Cho; Robert D Stevens
Journal:  Neurocrit Care       Date:  2022-09-07       Impact factor: 3.532

2.  Neuroprognostication Under ECMO After Cardiac Arrest: Are Classical Tools Still Performant?

Authors:  Nawfel Ben-Hamouda; Zied Ltaief; Matthias Kirsch; Jan Novy; Lucas Liaudet; Mauro Oddo; Andrea O Rossetti
Journal:  Neurocrit Care       Date:  2022-05-09       Impact factor: 3.532

3.  Dynamic Variables of Electroencephalography may be a Window into Brain Responsiveness.

Authors:  Paul Vespa
Journal:  Neurocrit Care       Date:  2022-09-30       Impact factor: 3.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.